Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
149.52
+3.19 (2.18%)
At close: Oct 30, 2026, 4:00 PM EDT
149.55
+0.03 (0.02%)
After-hours: Oct 30, 2026, 7:59 PM EDT

Merck & Co. Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
18,08516,60716,28616,40017,27615,80615,52915,62416,65716,11215,77514,63015,96215,03514,48713,83014,95914,59315,90113,521
Revenue Growth (YoY)
4.68%5.07%4.88%4.97%3.72%-1.90%-1.56%6.79%4.35%7.16%8.89%5.79%6.71%3.03%-8.89%2.28%13.72%27.99%49.63%23.50%
Cost of Revenue
3,3564,1283,8754,2953,7453,3923,3833,7073,8883,6793,4243,7954,2313,9923,8973,8433,8804,1495,3344,087
Gross Profit
14,72912,47912,41112,10513,53112,41412,14611,91712,76912,43312,35110,83511,73111,04310,5909,98711,07910,44410,5679,434
Selling, General & Admin
2,7422,7772,5662,7332,4812,4962,4042,6912,5432,5492,3182,6412,3412,5392,3632,5962,4342,4582,1812,767
Research & Development
4,5339,7423,5583,9974,0013,9953,5211,1295,8623,5003,3348,8483,3072,6223,0843,0623,5112,7762,5693,067
Operating Expenses
7,27512,5196,1246,7306,4826,4915,9253,8208,4056,0495,65211,4895,6485,1615,4475,6585,9455,2344,7505,834
Operating Income
7,454-406,2875,3757,0495,9236,2218,0974,3646,3846,699-6546,0835,8825,1434,3295,1345,2105,8173,600
Interest Expense
-546-525-479-411-327-305-313-328-330-310-303-310-317-277-242-235-244-240-243-209
Interest & Investment Income
52353569966910914612769737073109112954015745
Currency Exchange Gain (Loss)
-63-37-38-99-56-78-90-50-33-60-83-162-85-62-61-17-96-86-39-95
Other Non Operating Income (Expenses)
9594241-6991-67272444389.598122109.5219182130154135
EBT Excluding Unusual Items
6,906-5085,8474,9756,7625,6786,0187,7984,4006,1276,429-966.55,8525,7745,0624,3915,0165,0295,6963,476
Merger & Restructuring Charges
-581-417-9,549-1,360-390-779-205-3,643-279-177-902-401-199-10,934-1,289-107-175-258-12778
Gain (Loss) on Sale of Investments
401242168-19537310090-155-3156143100-33-175450-58-371-284-708405
Asset Writedown
------------779----713-887---275
Legal Settlements
-----------0.5---572.5-----
Other Unusual Items
-1,167------170-----------225
Pretax Income
5,559-683-3,5343,4206,7454,9995,9034,1704,0906,0065,670-2,0465,620-5,3353,6503,5133,5834,4874,8613,909
Income Tax Expense
492654709458958571818426929545903-82087063782549533053855485
Earnings From Continuing Operations
5,067-1,337-4,2432,9625,7874,4285,0853,7443,1615,4614,767-1,2264,750-5,9722,8253,0183,2533,9494,3073,824
Earnings From Discontinued Operations
--------------------62
Net Income to Company
5,067-1,337-4,2432,9625,7874,4285,0853,7443,1615,4614,767-1,2264,750-5,9722,8253,0183,2533,9494,3073,762
Minority Interest in Earnings
-2231-2-1-6-1-4-6-5--5-3-4-1-5-53-4
Net Income
5,065-1,335-4,2402,9635,7854,4275,0793,7433,1575,4554,762-1,2264,745-5,9752,8213,0173,2483,9444,3103,758
Net Income to Common
5,065-1,335-4,2402,9635,7854,4275,0793,7433,1575,4554,762-1,2264,745-5,9752,8213,0173,2483,9444,3103,758
Net Income Growth (YoY)
-12.45%---20.84%83.24%-18.84%6.66%--33.47%-68.81%-46.09%--34.55%-19.72%-28.88%155.28%35.58%-
Shares Outstanding (Basic)
2,4782,4702,4722,4882,4952,5102,5232,5372,5342,5342,5332,5332,5372,5392,5382,5362,5332,5312,5282,527
Shares Outstanding (Diluted)
2,4782,4702,4722,4882,4982,5132,5312,5372,5412,5442,5442,5332,5462,5392,5512,5482,5422,5402,5372,535
Shares Change (YoY)
-0.80%-1.71%-2.33%-1.93%-1.69%-1.22%-0.51%0.16%-0.20%0.20%-0.27%-0.59%0.16%-0.04%0.55%0.51%0.24%--0.16%0.20%
EPS (Basic)
2.04-0.54-1.721.192.321.762.011.481.252.151.88-0.481.87-2.351.111.191.281.561.701.49
EPS (Diluted)
2.04-0.54-1.721.192.321.762.011.481.242.141.87-0.481.86-2.351.111.181.281.551.701.48
EPS Growth (YoY)
-12.02%---19.28%86.99%-17.76%7.49%--33.33%-68.47%-45.31%--34.71%-20.00%-28.89%154.12%35.91%-

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-4,4772,9271,8246,8352,5291,1722,5138,5084,8462,229-7436,8152,7393323,2814,4763,1733,7773,823
Free Cash Flow Per Share
-1.811.180.732.741.010.460.993.351.910.88-0.292.681.080.131.291.761.251.491.51
Dividend Per Share
0.8500.8500.8500.8100.8100.8100.8100.7700.7700.7700.7700.7300.7300.7300.7300.6900.6900.6900.6900.650
Dividend Growth (YoY)
4.94%4.94%4.94%5.20%5.20%5.20%5.20%5.48%5.48%5.48%5.48%5.80%5.80%5.80%5.80%6.15%6.15%6.15%6.15%6.56%
Gross Margin
81.44%75.14%76.21%73.81%78.32%78.54%78.22%76.27%76.66%77.17%78.30%74.06%73.49%73.45%73.10%72.21%74.06%71.57%66.45%69.77%
Operating Margin
41.22%-0.24%38.60%32.77%40.80%37.47%40.06%51.82%26.20%39.62%42.47%-4.47%38.11%39.12%35.50%31.30%34.32%35.70%36.58%26.63%
Profit Margin
28.01%-8.04%-26.04%18.07%33.49%28.01%32.71%23.96%18.95%33.86%30.19%-8.38%29.73%-39.74%19.47%21.82%21.71%27.03%27.11%27.79%
Free Cash Flow Margin
-26.96%17.97%11.12%39.56%16.00%7.55%16.08%51.08%30.08%14.13%-5.08%42.70%18.22%2.29%23.72%29.92%21.74%23.75%28.27%
EBITDA
8,9221,4287,6916,7938,1476,9877,2799,2115,5107,4507,6182497,0616,7636,1135,1986,0726,1016,9084,404
EBITDA Margin
49.33%8.60%47.23%41.42%47.16%44.20%46.87%58.95%33.08%46.24%48.29%1.70%44.24%44.98%42.20%37.59%40.59%41.81%43.44%32.57%
D&A For EBITDA
1,4681,4681,4041,4181,0981,0641,0581,1141,1461,0669199039788819708699388911,091804
EBIT
7,454-406,2875,3757,0495,9236,2218,0974,3646,3846,699-6546,0835,8825,1434,3295,1345,2105,8173,600
EBIT Margin
41.22%-0.24%38.60%32.77%40.80%37.47%40.06%51.82%26.20%39.62%42.47%-4.47%38.11%39.12%35.50%31.30%34.32%35.70%36.58%26.63%
Effective Tax Rate
8.85%--13.39%14.20%11.42%13.86%10.22%22.71%9.07%15.93%-15.48%-22.60%14.09%9.21%11.99%11.40%2.17%
SEC Filings: 10-K · 10-Q